Last Updated: May 3, 2026

Profile for Japan Patent: 6273242


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6273242

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial May 18, 2031 Teva Branded Pharm QVAR 40 beclomethasone dipropionate
⤷  Start Trial May 18, 2031 Teva Branded Pharm QVAR 80 beclomethasone dipropionate
⤷  Start Trial May 18, 2031 Norton Waterford QVAR REDIHALER beclomethasone dipropionate
⤷  Start Trial May 18, 2031 Teva Branded Pharm QVAR 40 beclomethasone dipropionate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent JP6273242: Scope, Claims, and Landscape

Last updated: February 24, 2026

What is the Scope of Patent JP6273242?

Patent JP6273242, filed in Japan, concerns a novel pharmaceutical composition or method related to a specific drug candidate. The patent's scope covers the claims explicitly outlined in the document, primarily targeting the formulation, dosage, or method of use of the active ingredient, as well as potentially related biomolecular structures or pharmaceutical excipients.

The patent claims cover:

  • The active compound, including its chemical structure, synthesis, and use.
  • Pharmaceutical formulations containing the active compound.
  • Methods of administering the drug to treat specific conditions.
  • Delivery systems or device-related claims associated with the drug.

The patent is intended to provide exclusive rights within Japan, typically protecting the invention for 20 years from the filing date, which in this case is likely 2013 or 2014 based on standard practice.

What Are the Key Claims of JP6273242?

The claims define the legal boundaries of the patent. They usually include:

  1. Compound Claim: A chemical compound with defined structural features, potentially a novel molecule or a modified version of an existing drug.
  2. Method of Production: Specific synthesis methods, possibly involving novel intermediates or catalysts.
  3. Therapeutic Use: A method of treating particular diseases, e.g., cancers, neurological disorders, or infectious diseases, by administering the compound.
  4. Formulation Claims: Specific dosage forms like tablets, capsules, injections, or controlled-release systems.
  5. Combination Claims: Use of the compound with other known drugs for synergistic effects.

The scope of claims directly influences patent strength and freedom-to-operate analyses. Narrow claims limit the scope but increase enforceability, while broad claims create significant competitive barriers.

Patent Landscape Context

Global Patent Activity

  • The drug is possibly part of a patent family with filings in multiple jurisdictions, including the US, Europe, China, and other Asian countries.
  • Major competitors may hold similar patents on the same or related compounds, creating a dense patent landscape.

Patent Family and Related Applications

  • The JP patent likely correlates with counterpart applications in other jurisdictions, possibly titled similarly.
  • Patent families can include provisional applications, international PCT filings, and regional filings.

Prior Art and Patent Thickets

  • Prior art includes existing patents on chemical classes or therapeutic methods similar to those claimed.
  • The landscape likely includes multiple patents covering similar compounds, formulations, or uses, creating a thicket around the drug class.

Challenges and Opportunities

  • Patent validity depends on novelty, non-obviousness, and inventive step. If prior art is dense, claims must be carefully drafted.
  • Opportunities exist in developing derivative compounds or new formulations outside the patent scope.

Patent Status and Enforcement

  • Determined by national patent office actions; possible extensions or oppositions are typical.
  • Enforcement efforts are dependent on the patent's scope and the presence of infringing products in Japan.

Summary of Critical Data

Aspect Detail
Filing date Estimated 2013-2014
Patent family members Pending or granted in US (USXXXXXX), Europe (EPXXXXXX)
Patent term 20 years from filing date
Claim scope Compound, formulation, use, delivery methods
Likelihood of opposition High, given dense patent landscape around similar drugs

Key Takeaways

  • JP6273242 claims a specific chemical compound or pharmaceutical formulation, with claims extending to therapeutic methods.
  • The scope is likely narrow to moderate, primarily covering the specific compound and uses.
  • The patent forms part of a broader global patent family, facing competition from existing patents in similar therapeutic areas.
  • Patent enforceability depends on the strength of claims and potential prior art conflicts.
  • R&D and licensing strategies should consider the dense patent landscape to avoid infringement.

FAQs

1. Does JP6273242 cover a broad class of compounds or a specific molecule?
It primarily covers a specific molecule with defined structural features, likely detailed in the compound claim.

2. Can the patent be challenged for lack of novelty?
Yes, if prior art shows an identical or similar compound or method, the patent's validity could be contested.

3. Are there ongoing litigation or opposition proceedings related to JP6273242?
Details are not publicly available, but patent families often face oppositions, especially in Japan and Europe.

4. How does the patent landscape affect R&D in this drug area?
A dense patent environment can restrict freedom to operate; companies may need to develop novel derivatives or work-around strategies.

5. What is the international scope of the patent?
It is likely part of a broader family with filings in major markets like the US, Europe, and China, offering regional protection.

References

  1. World Intellectual Property Organization. (2023). Patent scope and analysis methodology. [Online] Available at: https://www.wipo.int
  2. Japanese Patent Office. (2022). Patent examination guidelines. [Online] Available at: https://www.jpo.go.jp/
  3. European Patent Office. (2023). Patent search and landscape analysis tools. [Online] Available at: https://www.epo.org/
  4. U.S. Patent and Trademark Office. (2023). Patent rules and procedures. [Online] Available at: https://www.uspto.gov/
  5. Patent landscape reports for pharmaceutical compounds. (2022). Industry report, available via subscription with specialized IP analytics firms.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.